Cel Sci (CVM) Deferred Taxes (2010 - 2018)
Cel Sci (CVM) posted Deferred Taxes of $1132.0 for Q1 2018, down 24.83% sequentially from $1506.0 in Q4 2017, and up 549.21% YoY from $174.37 in Q1 2017.
Cel Sci (CVM) Deferred Taxes (2010 - 2018) Analysis & Trends
Cel Sci has reported Deferred Taxes for 8 years, with the latest figure at $1132.0 in Q1 2018.
- Quarterly Deferred Taxes rose 549.21% year-over-year to $1132.0 in Q1 2018, while the trailing twelve-month figure through Mar 2018 was $6381.0 (up 258.42% YoY) and the FY2017 annual result came in at $1995.0, up 5.22% from the prior year.
- Deferred Taxes eased to $1132.0 in Q1 2018 per CVM's latest filing, from $1506.0 in the prior quarter.
- Over five years, Deferred Taxes peaked at $12153.0 in Q3 2015 and troughed at -$1496.0 in Q3 2016.
- A 4-year average of $1698.4 and a median of $1132.0 in 2018 frame the typical range for Deferred Taxes.
- The sharpest annual moves came in 2017 and 2018: Deferred Taxes plunged 265.22% in 2017, then surged 549.21% in 2018.
- Over 4 years, Deferred Taxes stood at $4245.0 in 2015, then plunged by 135.24% to -$1496.0 in 2016, then surged by 200.67% to $1506.0 in 2017, then fell by 24.83% to $1132.0 in 2018.
- According to Business Quant data, Deferred Taxes over the past three periods registered $1132.0, $1506.0, and $1505.0 for Q1 2018, Q4 2017, and Q3 2017 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.66 Bn | 131.80 Bn | 2.84 Bn | -69.70 Mn |
| 2 | Regeneron Pharmaceuticals | 86.52 Bn | 78.53 Bn | 3.93 Bn | 194.40 Mn |
| 3 | Argenx Se | 65.33 Bn | 60.14 Bn | 1.37 Bn | - |
| 4 | Moderna | 59.76 Bn | 54.62 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 42.15 Bn | 37.05 Bn | 1.53 Bn | - |
| 6 | Alnylam Pharmaceuticals | 31.84 Bn | 28.53 Bn | 992.69 Mn | 2.66 Mn |
| 7 | BioNTech SE | 28.23 Bn | 9.84 Bn | 668.28 Mn | - |
| 8 | Insmed | 27.52 Bn | 26.36 Bn | 358.27 Mn | - |
| 9 | Royalty Pharma | 27.29 Bn | 26.46 Bn | - | - |
| 10 | Cel Sci | 2.18 Mn | -4.36 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2018 | 1,132.00 |
| Dec 31, 2017 | 1,506.00 |
| Sep 30, 2017 | 1,505.00 |
| Jun 30, 2017 | 2,238.00 |
| Mar 31, 2017 | -252.00 |
| Dec 31, 2016 | -1,496.00 |
| Sep 30, 2016 | -1,496.00 |
| Jun 30, 2016 | -784.00 |
| Mar 31, 2016 | -69.00 |
| Dec 31, 2015 | 4,245.00 |
| Sep 30, 2015 | 12,153.00 |
| Mar 31, 2013 | -24.00 |
| Dec 31, 2012 | 688.00 |
| Sep 30, 2012 | 15,866.00 |
| Jun 30, 2012 | -1,121.00 |
| Mar 31, 2012 | -2,759.00 |
| Sep 30, 2011 | -1,509.00 |
| Jun 30, 2011 | -730.00 |
| Mar 31, 2011 | -730.00 |
| Dec 31, 2010 | -730.00 |